Breaking News Instant updates and real-time market news.

MXIM

Maxim Integrated

$93.60 /

-2.5 (-2.60%)

07:04
01/25/21
01/25
07:04
01/25/21
07:04

Maxim Integrated price target raised to $101 from $95 at Deutsche Bank

Deutsche Bank analyst Ross Seymore raised the firm's price target on Maxim Integrated to $101 from $95 and keeps a Buy rating on the shares. The analyst expects Maxim to benefit from apparent demand improvement across the semiconductor sector in both its December and March quarters, particularly in automotive and industrial.

MXIM Maxim Integrated
$93.60 /

-2.5 (-2.60%)

12/17/20 Deutsche Bank
Maxim Integrated price target raised to $95 from $90 at Deutsche Bank
11/25/20 Truist
Analog Devices price target raised to $164 from $136 at Truist
08/20/20 RBC Capital
Analog Devices price target raised to $135 from $130 at RBC Capital
07/29/20 BMO Capital
Maxim Integrated price target raised to $72 from $60 at BMO Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Evolus' Jeuveau on track for $100M annual net revenue run rate in Q2 » 16:25
05/12/21
05/12
16:25
05/12/21
16:25
EOLS

Evolus

$8.40 /

-0.34 (-3.89%)

"We believe Jeuveau…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

  • 22
    Apr
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

Earnings
Marker Therapeutics reports Q1 EPS , consensus (14c) » 16:25
05/12/21
05/12
16:25
05/12/21
16:25
MRKR

Marker Therapeutics

$2.17 /

-0.175 (-7.48%)

At March 31, Marker had…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRKR Marker Therapeutics
$2.17 /

-0.175 (-7.48%)

MRKR Marker Therapeutics
$2.17 /

-0.175 (-7.48%)

03/25/21 Piper Sandler
Marker Therapeutics initiated with an Overweight at Piper Sandler
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Cantor Fitzgerald
Cantor Fitzgerald starts 'undervalued' Marker Therapeutics at Overweight
03/18/21 Cantor Fitzgerald
Marker Therapeutics initiated with an Overweight at Cantor Fitzgerald
  • 12
    Mar
MRKR Marker Therapeutics
$2.17 /

-0.175 (-7.48%)

General news
Treasury Market Summary » 16:25
05/12/21
05/12
16:25
05/12/21
16:25
$ECON

Economic Data

/

+

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Earnings
    1Life Healthcare reports Q1 EPS (29c), consensus (15c) » 16:24
    05/12/21
    05/12
    16:24
    05/12/21
    16:24
    ONEM

    1Life Healthcare

    $38.27 /

    -0.49 (-1.26%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ONEM 1Life Healthcare
    $38.27 /

    -0.49 (-1.26%)

    ONEM 1Life Healthcare
    $38.27 /

    -0.49 (-1.26%)

    05/03/21 Jefferies
    Jefferies confident in path to 'much larger' 1Life Healthcare, starts at Buy
    05/03/21 Jefferies
    1Life Healthcare initiated with a Buy at Jefferies
    04/26/21 Piper Sandler
    Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
    04/08/21 Piper Sandler
    1Life app downloads suggest Q1 beat, says Piper Sandler
    ONEM 1Life Healthcare
    $38.27 /

    -0.49 (-1.26%)

    • 23
      Nov
    • 25
      Jun
    ONEM 1Life Healthcare
    $38.27 /

    -0.49 (-1.26%)

    ONEM 1Life Healthcare
    $38.27 /

    -0.49 (-1.26%)

    Earnings
    Zovio reports Q1 adjusted EPS (10c), consensus (1c) » 16:24
    05/12/21
    05/12
    16:24
    05/12/21
    16:24
    ZVO

    Zovio

    $3.47 /

    +0.14 (+4.20%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ZVO Zovio
    $3.47 /

    +0.14 (+4.20%)

    ZVO Zovio
    $3.47 /

    +0.14 (+4.20%)

    04/09/21
    Fly Intel: Top five analyst initiations
    04/09/21 Northland
    Zovio initiated with an Outperform at Northland
    01/06/21 Barrington
    Imax and Sirius XM among Barrington's best ideas for 2021
    08/03/20 Barrington
    Zovio price target raised to $10 from $8 at Barrington
    ZVO Zovio
    $3.47 /

    +0.14 (+4.20%)

    ZVO Zovio
    $3.47 /

    +0.14 (+4.20%)

    Earnings
    A-Mark Precious Metals reports Q3 EPS $8.84, consensus $2.88 » 16:24
    05/12/21
    05/12
    16:24
    05/12/21
    16:24
    AMRK

    A-Mark Precious Metals

    $39.00 /

    -1.71 (-4.20%)

    Reports Q3 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    AMRK A-Mark Precious Metals
    $39.00 /

    -1.71 (-4.20%)

    AMRK A-Mark Precious Metals
    $39.00 /

    -1.71 (-4.20%)

    03/19/21 DA Davidson
    A-Mark Precious Metals initiated with a Buy at DA Davidson
    03/18/21 DA Davidson
    A-Mark Precious Metals initiated with a Buy at DA Davidson
    02/10/21 Roth Capital
    A-Mark Precious Metals price target raised to $60 from $45 at Roth Capital
    09/28/20 Roth Capital
    A-Mark Precious Metals price target raised to $45 from $33 at Roth Capital
    AMRK A-Mark Precious Metals
    $39.00 /

    -1.71 (-4.20%)

    • 04
      Mar
    Earnings
    Evolus reports Q1 diluted EPS 16c, may not compare to consensus (43c) » 16:24
    05/12/21
    05/12
    16:24
    05/12/21
    16:24
    EOLS

    Evolus

    $8.40 /

    -0.34 (-3.89%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    EOLS Evolus
    $8.40 /

    -0.34 (-3.89%)

    EOLS Evolus
    $8.40 /

    -0.34 (-3.89%)

    05/06/21 Mizuho
    Evolus upgraded to Buy from Neutral at Mizuho
    04/08/21 H.C. Wainwright
    Evolus price target raised to $22 from $20 at H.C. Wainwright
    03/30/21 Mizuho
    Evolus price target raised to $15 from $9 at Mizuho
    03/24/21 H.C. Wainwright
    Evolus price target raised to $20 from $18 at H.C. Wainwright
    EOLS Evolus
    $8.40 /

    -0.34 (-3.89%)

    • 22
      Apr
    EOLS Evolus
    $8.40 /

    -0.34 (-3.89%)

    EOLS Evolus
    $8.40 /

    -0.34 (-3.89%)

    EOLS Evolus
    $8.40 /

    -0.34 (-3.89%)

    Hot Stocks
    CVS Health: COVID-19 vaccine appointments now available for ages 12-15 » 16:23
    05/12/21
    05/12
    16:23
    05/12/21
    16:23
    CVS

    CVS Health

    $83.34 /

    -1.05 (-1.24%)

    , PFE

    Pfizer

    $39.69 /

    +0.35 (+0.89%)

    , BNTX

    BioNTech

    $186.00 /

    -12.6 (-6.34%)

    CVS Health (CVS)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CVS CVS Health
    $83.34 /

    -1.05 (-1.24%)

    PFE Pfizer
    $39.69 /

    +0.35 (+0.89%)

    BNTX BioNTech
    $186.00 /

    -12.6 (-6.34%)

    CVS CVS Health
    $83.34 /

    -1.05 (-1.24%)

    06:46 Today Mizuho
    CVS Health price target raised to $98 from $82 at Mizuho
    05/06/21 Credit Suisse
    CVS Health price target raised to $100 from $91 at Credit Suisse
    05/06/21 BMO Capital
    CVS Health price target raised to $90 from $82 at BMO Capital
    05/05/21 Jefferies
    CVS Health price target raised to $95 from $90 at Jefferies
    PFE Pfizer
    $39.69 /

    +0.35 (+0.89%)

    10:47 Today Canaccord
    BioNTech price target raised to $240 from $130 at Canaccord
    05/11/21 SVB Leerink
    BioNTech price target raised to $159 from $118 at SVB Leerink
    05/10/21 Morgan Stanley
    Pfizer price target raised to $42 from $38 at Morgan Stanley
    05/06/21
    Fly Intel: Top five analyst downgrades
    BNTX BioNTech
    $186.00 /

    -12.6 (-6.34%)

    10:47 Today Canaccord
    BioNTech price target raised to $240 from $130 at Canaccord
    05/11/21
    Fly Intel: Top five analyst downgrades
    05/11/21 SVB Leerink
    BioNTech price target raised to $159 from $118 at SVB Leerink
    05/11/21 Bryan Garnier
    BioNTech downgraded to Neutral from Buy at Bryan Garnier
    CVS CVS Health
    $83.34 /

    -1.05 (-1.24%)

    PFE Pfizer
    $39.69 /

    +0.35 (+0.89%)

    BNTX BioNTech
    $186.00 /

    -12.6 (-6.34%)

    • 23
      Jul
    CVS CVS Health
    $83.34 /

    -1.05 (-1.24%)

    PFE Pfizer
    $39.69 /

    +0.35 (+0.89%)

    BNTX BioNTech
    $186.00 /

    -12.6 (-6.34%)

    CVS CVS Health
    $83.34 /

    -1.05 (-1.24%)

    PFE Pfizer
    $39.69 /

    +0.35 (+0.89%)

    BNTX BioNTech
    $186.00 /

    -12.6 (-6.34%)

    CVS CVS Health
    $83.34 /

    -1.05 (-1.24%)

    PFE Pfizer
    $39.69 /

    +0.35 (+0.89%)

    BNTX BioNTech
    $186.00 /

    -12.6 (-6.34%)

    Earnings
    Resonant reports Q1 EPS (15c), consensus (10c) » 16:22
    05/12/21
    05/12
    16:22
    05/12/21
    16:22
    RESN

    Resonant

    $2.58 /

    -0.3 (-10.42%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    RESN Resonant
    $2.58 /

    -0.3 (-10.42%)

    RESN Resonant
    $2.58 /

    -0.3 (-10.42%)

    RESN Resonant
    $2.58 /

    -0.3 (-10.42%)

    Hot Stocks
    Silvergate to be exclusive issuer of U.S. dollar backed stablecoins by Diem » 16:22
    05/12/21
    05/12
    16:22
    05/12/21
    16:22
    SI

    Silvergate Capital

    $80.96 /

    -4.06 (-4.78%)

    Silvergate Capital…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SI Silvergate Capital
    $80.96 /

    -4.06 (-4.78%)

    SI Silvergate Capital
    $80.96 /

    -4.06 (-4.78%)

    04/13/21 Barclays
    Silvergate Capital price target raised to $165 from $85 at Barclays
    03/30/21 Canaccord
    Silvergate Capital price target raised to $150 from $90 at Canaccord
    03/02/21 Wedbush
    Silvergate Capital price target raised to $175 from $150 at Wedbush
    02/04/21 Craig-Hallum
    Silvergate Capital price target raised to $135 from $80 at Craig-Hallum
    SI Silvergate Capital
    $80.96 /

    -4.06 (-4.78%)

    • 22
      Jan
    SI Silvergate Capital
    $80.96 /

    -4.06 (-4.78%)

    SI Silvergate Capital
    $80.96 /

    -4.06 (-4.78%)

    SI Silvergate Capital
    $80.96 /

    -4.06 (-4.78%)

    Earnings
    Eastman Kodak reports Q1 revenue $209M vs $210 last year » 16:21
    05/12/21
    05/12
    16:21
    05/12/21
    16:21
    KODK

    Eastman Kodak

    $6.80 /

    -0.39 (-5.42%)

    Reports Q1 net income $6M…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    KODK Eastman Kodak
    $6.80 /

    -0.39 (-5.42%)

    KODK Eastman Kodak
    $6.80 /

    -0.39 (-5.42%)

    KODK Eastman Kodak
    $6.80 /

    -0.39 (-5.42%)

    KODK Eastman Kodak
    $6.80 /

    -0.39 (-5.42%)

    Earnings
    Evoke Pharma reports Q1 EPS (8c), consensus (6c) » 16:21
    05/12/21
    05/12
    16:21
    05/12/21
    16:21
    EVOK

    Evoke Pharma

    $1.53 /

    -0.02 (-1.29%)

    Reports Q1 revenue $90K,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    EVOK Evoke Pharma
    $1.53 /

    -0.02 (-1.29%)

    EVOK Evoke Pharma
    $1.53 /

    -0.02 (-1.29%)

    06/22/20 H.C. Wainwright
    Evoke Pharma upgraded to Buy from Neutral at H.C. Wainwright
    • 14
      Jan
    Downgrade
    Ferro downgraded to Neutral from Buy at Seaport Global » 16:21
    05/12/21
    05/12
    16:21
    05/12/21
    16:21
    FOE

    Ferro

    /

    +

    Seaport Global analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    FOE Ferro
    /

    +

    FOE Ferro
    /

    +

    08:25 Today Gabelli
    Ferro downgraded to Sell from Buy at Gabelli
    06:48 Today Deutsche Bank
    Ferro downgraded on 'fair but not full' buyout price at Deutsche Bank
    06:00 Today JPMorgan
    Ferro downgraded to Underweight from Neutral at JPMorgan
    05/11/21 Deutsche Bank
    Ferro downgraded to Hold from Buy at Deutsche Bank
    FOE Ferro
    /

    +

    FOE Ferro
    /

    +

    Hot Stocks
    AllianceBernstein reports preliminary AUM $724B as of April 30 » 16:21
    05/12/21
    05/12
    16:21
    05/12/21
    16:21
    AB

    AllianceBernstein

    $41.72 /

    -1.72 (-3.96%)

    Up from $697 B at the end…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AB AllianceBernstein
    $41.72 /

    -1.72 (-3.96%)

    AB AllianceBernstein
    $41.72 /

    -1.72 (-3.96%)

    05/11/21 Truist
    Equitable Holdings price target raised to $43 from $37 at Truist
    04/09/21 BofA
    BofA downgrades AllianceBernstein to Neutral, sees weaker near-term performance
    04/09/21 BofA
    AllianceBernstein downgraded to Neutral from Buy at BofA
    04/05/21 Keefe Bruyette
    AllianceBernstein downgraded to Market Perform from Outperform at Keefe Bruyette
    AB AllianceBernstein
    $41.72 /

    -1.72 (-3.96%)

    AB AllianceBernstein
    $41.72 /

    -1.72 (-3.96%)

    Initiation
    Microsoft initiated with a Buy at Rosenblatt » 16:21
    05/12/21
    05/12
    16:21
    05/12/21
    16:21
    MSFT

    Microsoft

    $239.05 /

    -7.18 (-2.92%)

    Rosenblatt analyst John…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MSFT Microsoft
    $239.05 /

    -7.18 (-2.92%)

    MSFT Microsoft
    $239.05 /

    -7.18 (-2.92%)

    05/11/21 Morgan Stanley
    Morgan Stanley downgrades Nuance, doesn't see Microsoft deal being beat
    05/07/21 LightShed Partners
    LightShed Partners starts Roblox at Buy with $85 price target
    04/28/21 Wedbush
    Microsoft price target raised to $310 from $300 at Wedbush
    04/28/21 Oppenheimer
    Microsoft reports 'impressive' Q3 as cloud momentum continues, says Oppenheimer
    MSFT Microsoft
    $239.05 /

    -7.18 (-2.92%)

    MSFT Microsoft
    $239.05 /

    -7.18 (-2.92%)

    MSFT Microsoft
    $239.05 /

    -7.18 (-2.92%)

    MSFT Microsoft
    $239.05 /

    -7.18 (-2.92%)

    Hot Stocks
    Salesforce urges shareholders to reject 'mini-tender' offer by Tutanota » 16:20
    05/12/21
    05/12
    16:20
    05/12/21
    16:20
    CRM

    Salesforce

    $210.53 /

    -5.1 (-2.37%)

    Salesforce announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CRM Salesforce
    $210.53 /

    -5.1 (-2.37%)

    CRM Salesforce
    $210.53 /

    -5.1 (-2.37%)

    05/03/21 BofA
    BofA adds Disney and Avalara, removes Comcast and Netflix from U.S. 1 List
    04/22/21 Wolfe Research
    Salesforce initiated with an Outperform at Wolfe Research
    04/05/21 Credit Suisse
    Salesforce assumed with an Outperform at Credit Suisse
    03/24/21 Nord/LB
    Salesforce downgraded to Hold from Buy at Nord/LB
    CRM Salesforce
    $210.53 /

    -5.1 (-2.37%)

    CRM Salesforce
    $210.53 /

    -5.1 (-2.37%)

    CRM Salesforce
    $210.53 /

    -5.1 (-2.37%)

    CRM Salesforce
    $210.53 /

    -5.1 (-2.37%)

    Options
    Closing CBOE SPX and VIX Index summary for May 12th » 16:20
    05/12/21
    05/12
    16:20
    05/12/21
    16:20
    VIX

    Volatility Index S&P 500 Options

    /

    +

    The CBOE Volatility Index…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    VIX Volatility Index S&P 500 Options
    /

    +

    Earnings
    Fuel Tech reports Q1 EPS 1c, consensus 6c » 16:19
    05/12/21
    05/12
    16:19
    05/12/21
    16:19
    FTEK

    Fuel Tech

    $1.94 /

    +0.025 (+1.31%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    FTEK Fuel Tech
    $1.94 /

    +0.025 (+1.31%)

    FTEK Fuel Tech
    $1.94 /

    +0.025 (+1.31%)

    Hot Stocks
    CPSI acquires TruCode, terms not disclosed » 16:19
    05/12/21
    05/12
    16:19
    05/12/21
    16:19
    CPSI

    Computer Programs

    $29.73 /

    -0.51 (-1.69%)

    CPSI announced that it…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CPSI Computer Programs
    $29.73 /

    -0.51 (-1.69%)

    CPSI Computer Programs
    $29.73 /

    -0.51 (-1.69%)

    06:52 Today Deutsche Bank
    Computer Programs price target lowered to $28 from $33 at Deutsche Bank
    02/16/21 Piper Sandler
    Computer Programs price target raised to $30 from $27 at Piper Sandler
    01/08/21 SVB Leerink
    Computer Programs assumed with an Outperform at SVB Leerink
    09/10/20 KeyBanc
    Computer Programs upgraded to Sector Weight from Underweight at KeyBanc
    CPSI Computer Programs
    $29.73 /

    -0.51 (-1.69%)

    CPSI Computer Programs
    $29.73 /

    -0.51 (-1.69%)

    Earnings
    PLBY Group reports Q1 revenue $42.7M, consensus $38.47M » 16:19
    05/12/21
    05/12
    16:19
    05/12/21
    16:19
    PLBY

    PLBY Group

    $41.59 /

    -4.41 (-9.59%)

    Reports Q1 adjusted…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PLBY PLBY Group
    $41.59 /

    -4.41 (-9.59%)

    PLBY PLBY Group
    $41.59 /

    -4.41 (-9.59%)

    04/07/21 Roth Capital
    PLBY Group price target raised to $35 from $26 at Roth Capital
    04/06/21 Canaccord
    Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
    03/31/21 Canaccord
    PLBY Group initiated with a Buy at Canaccord
    03/24/21 Craig-Hallum
    PLBY Group price target raised to $35 from $25 at Craig-Hallum
    PLBY PLBY Group
    $41.59 /

    -4.41 (-9.59%)

    PLBY PLBY Group
    $41.59 /

    -4.41 (-9.59%)

    PLBY PLBY Group
    $41.59 /

    -4.41 (-9.59%)

    PLBY PLBY Group
    $41.59 /

    -4.41 (-9.59%)

    Earnings
    cbdMD sees Q3 revenue $15.5M-$16.25M, consensus $13.53M  16:19
    05/12/21
    05/12
    16:19
    05/12/21
    16:19
    YCBD

    cbdMD

    $3.48 /

    +0.05 (+1.46%)

     
    ShowHide Related Items >><<
    YCBD cbdMD
    $3.48 /

    +0.05 (+1.46%)

    YCBD cbdMD
    $3.48 /

    +0.05 (+1.46%)

    YCBD cbdMD
    $3.48 /

    +0.05 (+1.46%)

    YCBD cbdMD
    $3.48 /

    +0.05 (+1.46%)

    Earnings
    Trean Insurance reports Q1 EPS 16c, consensus 19c » 16:19
    05/12/21
    05/12
    16:19
    05/12/21
    16:19
    TIG

    Trean Insurance

    $16.75 /

    -0.535 (-3.10%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TIG Trean Insurance
    $16.75 /

    -0.535 (-3.10%)

    01/04/21 JPMorgan
    Trean Insurance price target lowered to $17 from $18 at JPMorgan
    08/14/20 William Blair
    Trean Insurance initiated with an Outperform at William Blair
    08/10/20
    Fly Intel: Top five analyst initiations
    08/10/20 JPMorgan
    Trean Insurance initiated with a Neutral at JPMorgan
    TIG Trean Insurance
    $16.75 /

    -0.535 (-3.10%)

    • 16
      Jul
    Earnings
    Viracta Therapeutics reports Q1 EPS ($5.22), consensus (21c) » 16:19
    05/12/21
    05/12
    16:19
    05/12/21
    16:19
    VIRX

    Viracta Therapeutics

    $9.20 /

    +0.38 (+4.31%)

    Cash and cash equivalents…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    VIRX Viracta Therapeutics
    $9.20 /

    +0.38 (+4.31%)

    VIRX Viracta Therapeutics
    $9.20 /

    +0.38 (+4.31%)

    05/03/21 H.C. Wainwright
    Viracta Therapeutics initiated with a Buy at H.C. Wainwright
    04/26/21 SVB Leerink
    SVB Leerink bullish on Viracta Therapeutics, initiates with an Outperform
    04/26/21 SVB Leerink
    Viracta Therapeutics initiated with an Outperform at SVB Leerink
    03/25/21
    Fly Intel: Top five analyst initiations
    Hot Stocks
    Cal-Maine Foods acquires remaining interest in Red River Valley Egg Farm » 16:18
    05/12/21
    05/12
    16:18
    05/12/21
    16:18
    CALM

    Cal-Maine Foods

    $36.90 /

    -0.905 (-2.39%)

    Cal-Maine Foods announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CALM Cal-Maine Foods
    $36.90 /

    -0.905 (-2.39%)

    CALM Cal-Maine Foods
    $36.90 /

    -0.905 (-2.39%)

    12/30/20 Stephens
    Cal-Maine Foods price target lowered to $47 from $55 at Stephens
    10/28/20
    Fly Intel: Top five analyst initiations
    10/28/20 BofA
    Cal-Maine Foods initiated with a Buy at BofA
    10/28/20 BofA
    Cal-Maine Foods initiated with a Buy at BofA
    CALM Cal-Maine Foods
    $36.90 /

    -0.905 (-2.39%)

    • 20
      Aug
    CALM Cal-Maine Foods
    $36.90 /

    -0.905 (-2.39%)

    CALM Cal-Maine Foods
    $36.90 /

    -0.905 (-2.39%)

    Earnings
    AppLovin sees FY21 revenue $2.65B-$2.7B, or 83% growth » 16:18
    05/12/21
    05/12
    16:18
    05/12/21
    16:18
    APP

    AppLovin

    $52.11 /

    -1.2 (-2.25%)

    Sees FY21 adjusted EBITDA…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    APP AppLovin
    $52.11 /

    -1.2 (-2.25%)

    05/10/21
    Fly Intel: Top five analyst initiations
    05/10/21 Stifel
    AppLovin initiated with a Hold at Stifel
    05/10/21 UBS
    AppLovin initiated with a Buy at UBS
    05/10/21 Truist
    AppLovin initiated with a Buy at Truist
    APP AppLovin
    $52.11 /

    -1.2 (-2.25%)

    • 15
      Apr
    APP AppLovin
    $52.11 /

    -1.2 (-2.25%)

    APP AppLovin
    $52.11 /

    -1.2 (-2.25%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.